Detalhe da pesquisa
1.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37439329
2.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Hematol Oncol
; 42(4): e3290, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38818978
3.
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience.
Ann Hematol
; 2024 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38805036
4.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36692409
5.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36335916
6.
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region.
Ann Hematol
; 102(10): 2923-2931, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37442822
7.
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphoma.
Ann Hematol
; 102(2): 385-392, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36645458
8.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol
; 40(4): 704-715, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35608183
9.
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
Eur J Haematol
; 108(3): 178-189, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34716957
10.
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation.
Support Care Cancer
; 30(2): 1521-1527, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34533630
11.
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol.
Haematologica
; 106(7): 1828-1838, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33538150
12.
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP).
Ann Hematol
; 100(2): 429-436, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33161453
13.
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).
Ann Hematol
; 98(2): 361-367, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30353388
14.
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).
Ann Hematol
; 97(10): 1817-1824, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30054707
15.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Am J Hematol
; 98(8): E204-E208, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37222267
16.
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
Qual Life Res
; 27(6): 1545-1554, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29520559
17.
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Br J Haematol
; 172(1): 111-21, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26458240
18.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Haematologica
; 106(1): 291-294, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32107338
19.
The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
Ann Hematol
; 95(2): 239-44, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26596973
20.
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
Eur J Haematol
; 96(1): 36-45, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25753656